A Study of GR1014 Cutaneous Gel for the Prevention of Skin Reactions Caused by Radiation Therapy for Breast Cancer
Clinical trial NCT07192588 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07192588
- Sponsor
- Graegis Pharmaceuticals Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-26
- Primary completion
- 2026-09-30
- Enrollment
- 273
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.